Symmetric Group Sequential Test Designs

DOI10.2307/2531692MaRDI QIDQ3201548zbMATH OpenOpenAlexWikidataFDO

Authors Scott S. Emerson, Thomas Fleming

Publication date 1989

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://semanticscholar.org/paper/9650c53ef5172df79b7c2587a0e8a71b5d07c4f2

zbMATH Keywords

clinicial trial designsGroup sequential test designsinterim analysesPhase III clinical trialsstopping boundariessymmetric designssymmetric one-sided group sequential designsunequal group sizes

Mathematics Subject Classification ID

Sequential statistical design (62L05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• Optimal asymmetric one-sided group sequential tests
• scientific article; zbMATH DE number 1348603
• Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis
• Three-stage designs for monitoring clinical trials
• Bias of the lse estimator of the first order autoregressive model under tukey contamination

Cited in

(24)

• Truncated group sequential test for clinical trials
• Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis
• Basic concepts of group sequential and adaptive group sequential test procedures
• Asymmetric group sequential designs under fractional Brownian motion
• Estimation of a secondary parameter in a group sequential clinical trial
• Principles of Optimal Sequential Planning
• Approximately Optimal One-Parameter Boundaries for Group Sequential Trials
• Group sequential designs using both type I and type II error probability spending functions
• Group Sequential Monitoring with Arbitrary Inspection Times
• GROUP SEQUENTIAL TESTS WITH OUTCOME-DEPENDENT TREATMENT ASSIGNMENT
• Optimal asymmetric one-sided group sequential tests
• A Unifying Family of Group Sequential Test Designs
• CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH₀
• Three-stage designs for monitoring clinical trials
• Interim evaluation of efficacy or futility in group‐sequential trials with multiple co‐primary endpoints
• Unbalanced and partial group sequential methods for normal responses in clinical trials
• On group sequential tests for data in unequally sized groups and with unknown variance
• Asymptotically optimal multistage tests for non-i.i.d. data
• Group sequential designs for clinical trials with bivariate endpoints
• Dual-criterion approach incorporating historical information to seek accelerated approval with application in time-to-event group sequential trials
• Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring
• Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalence
• Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation
• Comparison of numerical algorithms for bivariate sequential tests based on marginal criteria

This page was built for publication: Symmetric Group Sequential Test Designs

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201548)